Login to Your Account



Patent-Case Ruling In Tercica Fight With Insmed; Trial Slated

By Randall Osborne


Thursday, July 6, 2006
Insmed Inc.'s news that European regulators validated its application for Iplex for children with short stature associated with severe primary insulin-like growth factor 1 deficiency (IGFD) was overshadowed by word of a court ruling in a patent case brought by Tercica Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription